» Articles » PMID: 27048173

Changes in Seroprevalence of Hepatitis B Surface Antigen and Epidemiologic Characteristics in the Republic of Korea, 1998-2013

Overview
Specialty Public Health
Date 2016 Apr 7
PMID 27048173
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study investigated changes in hepatitis B seroprevalence from 1998 to 2013, and to identify differences in epidemiologic characteristics between hepatitis B surface antigen (HBsAg)-positive and HBsAg-negative people.

Methods: HBsAg seropositive rates were compared by year, sex, and age using the blood test data from the periods I to VI (1998-2013) of the Korea National Health and Nutrition Examination Survey. Interviews and self-administered surveys were conducted to collect data on health behavior, quality of life, comorbidities, and health care utilization.

Results: HBsAg seropositive rates in the Republic of Korea decreased from 4.6% in 1998 to 2.9% in 2008, and then remained the same for the next five years. While seropositive rates by age were the highest at 35 to 39 years of age in 1998, it peaked at 50 to 54 years of age in 2013. HBsAg-positive people showed high values from two liver function tests, including glutamic-oxaloacetic transaminase and glutamic-pyruvic transaminase, and the prevalence rates of liver cirrhosis and liver cancer were also significantly high. Indices for health behavior and quality of life showed no significant differences between HBsAg-positive and HBsAg-negative people.

Conclusions: While HBsAg seropositive rates tended to decline after 1998, there have been no significant changes over the most recent five years. We should focus on treatment of existing hepatitis B patients along with immunization programmes to prevent new hepatitis B infections. In addition, it may be necessary to encourage HBsAg-positive people to follow healthier life-styles in order to prevent further progression of hepatitis B to liver cirrhosis and liver cancer.

Citing Articles

Korea National Health and Nutrition Examination Survey, 20th anniversary: accomplishments and future directions.

Oh K, Kim Y, Kweon S, Kim S, Yun S, Park S Epidemiol Health. 2021; 43:e2021025.

PMID: 33872484 PMC: 8289475. DOI: 10.4178/epih.e2021025.


Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea.

Chang J, Jung S, Moon C, Kim S, Jung H, Shim K Intest Res. 2018; 16(4):599-608.

PMID: 30301330 PMC: 6223458. DOI: 10.5217/ir.2018.00012.


Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.

Kim B, Oh C, Choi H, Park J, Cho H, Ki M Gut Liver. 2018; 13(1):104-113.

PMID: 29938462 PMC: 6347005. DOI: 10.5009/gnl18105.


Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea.

Kim H, Chung Y, Kim I Ann Occup Environ Med. 2018; 30:6.

PMID: 29423229 PMC: 5791172. DOI: 10.1186/s40557-018-0217-0.


Identification of Novel A2/C2 Inter-Genotype Recombinants of Hepatitis B Virus from a Korean Chronic Patient Co-Infected with Both Genotype A2 and C2.

Lee S, Lee S, Kim J, Kim H, Kim K, Kook Y Int J Mol Sci. 2017; 18(4).

PMID: 28358313 PMC: 5412322. DOI: 10.3390/ijms18040737.

References
1.
Chevillotte G, Durbec J, GEROLAMI A, Berthezene P, Bidart J, CAMATTE R . Interaction between hepatitis b virus and alcohol consumption in liver cirrhosis. An epidemiologic study. Gastroenterology. 1983; 85(1):141-5. View

2.
Ohnishi K, Terabayashi H, Unuma T, Takahashi A, Okuda K . Effects of habitual alcohol intake and cigarette smoking on the development of hepatocellular carcinoma. Alcohol Clin Exp Res. 1987; 11(1):45-8. DOI: 10.1111/j.1530-0277.1987.tb01260.x. View

3.
Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M . Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut. 1998; 41(6):845-50. PMC: 1891602. DOI: 10.1136/gut.41.6.845. View

4.
. KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol. 2012; 18(2):109-62. PMC: 3415874. DOI: 10.3350/cmh.2012.18.2.109. View

5.
Chen C, Yang H, Su J, Jen C, You S, Lu S . Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006; 295(1):65-73. DOI: 10.1001/jama.295.1.65. View